[Table, CER 10 - Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension].

Paul Shekelle(VA Palo Alto Health Care System), Jennifer Grossman, Roberta Shanman(RAND Corporation), Dena M Bravata(VA Palo Alto Health Care System), Jason Carter(Washington University in St. Louis), Sydne J Newberry, Breanne Johnsen, Zhen Wang(Mayo Clinic), Michael Chen(Taichung Veterans General Hospital), Aneesa Motala(University of Southern California), Margaret Maglione(Center for Neurologic Study), Ben Hulley
Unknown
September 10, 2009
Cited by 0

Related Papers

Patient engagement in research: a systematic review
|BMC Health Services Research|2014|1.8k
Preventing 30-Day Hospital Readmissions
|JAMA Internal Medicine|2014|1k
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials
|The Lancet|2009|746
Patient and service user engagement in research: a systematic review and synthesized framework
|Health Expectations|2013|660
Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid
|Nature Genetics|2004|401